AptaBio Therapeutics Market Cap

AptaBio Therapeutics has a market cap or net worth of 185.98 billion as of March 9, 2026. Its market cap has decreased by -6.76% in one year.

Market Cap

185.98B

Enterprise Value

175.20B

Revenue

3.44B

Ranking

n/a

PE Ratio

n/a

Stock Price

6,620.00

Market Cap Chart

Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 185.98B, a decrease of -56.06%. That is a compound annual growth rate of -11.48%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	185.98B	-26.01%
Dec 30, 2025	251.34B	46.78%
Dec 30, 2024	171.23B	-15.15%
Dec 28, 2023	201.80B	-15.02%
Dec 29, 2022	237.48B	-71.24%
Dec 30, 2021	825.71B	46.50%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
REYON Pharmaceutical	191.66B
JW Lifescience	200.22B
Jeil Pharmaceutical Co.,Ltd	210.56B
HLB Pharmaceutical	212.04B
SAMSUNG PHARM. Co., LTD.	175.44B
Hana Pharm	174.00B
Daihan Pharmaceutical	172.87B
Dongwha Pharm.Co.,Ltd	171.02B

Market Cap Rankings